Trial reportParasite (Paris, France)2017
Assessment of the insecticidal activity of afoxolaner against Aedes aegypti in dogs treated with NexGard
Trial report in Parasite (Paris, France), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 21 citations in OpenAlex.
- Safeguarding Canadian pets and humans: A call to strengthen regulations for importing companion animals.Canadian journal of veterinary research = Revue canadienne de recherche veterinaire · 2026Review
- Model development to assess the impact of a preventive treatment with sarolaner and moxidectin on Dirofilaria immitis infection dynamics in dogs.Parasites & vectors · 2025Article
- Fluralaner (BravectoParasites & vectors · 2023Article
- Inability of Dirofilaria immitis infective larvae from mosquitoes fed on blood from microfilaremic dogs during low-dose and short-treatment regimens of doxycycline and ivermectin to complete normal development in heartworm naïve dogs.Parasites & vectors · 2023Article
- Insecticidal activity of Simparica and Simparica Trio against Aedes aegypti in dogs.Parasites & vectors · 2023Article
- Efficacy of a topical product combining esafoxolaner, eprinomectin and praziquantel against bedbug (Cimex lectularius) experimental infestations in cats.Parasite (Paris, France) · 2022Article
- Efficacy of afoxolaner (NexGard®) in preventing the transmission of Leishmania infantum and Dirofilaria immitis to sheltered dogs in a highly endemic area.Parasites & vectors · 2021Article
- Insecticidal efficacy of afoxolaner againstCurrent research in parasitology & vector-borne diseases · 2021Article
- Insecticidal efficacy of afoxolaner against bedbugs, Cimex lectularius, when administered orally to dogs.Parasite (Paris, France) · 2021Article
- Recent Advancements in the Control of Cat Fleas.Insects · 2020Review
- Assessment of the insecticidal activity of oral afoxolaner against Phlebotomus perniciosus in dogs.Parasite (Paris, France) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 3 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Twelve healthy dogs were studied in this parallel group, blinded, randomised, and negative controlled efficacy study. On Day -1, the 12 dogs included were ranked within sex in descending order of individual pre-treatment (Day -5) fed mosquito counts and randomly allocated by blocks of two dogs to the untreated control group or the afoxolaner-treated group. NexGard
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.